Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the safety and tolerability of trichostatin A in
individuals with relapsed or refractory hematologic malignancies.